Axonics
IPO- Business Model
- B2B
- Website
- axonics.com
- Total Funding
- $125.3M
- Last Round
- $20.1M Series DApr 2018
- Rounds
- 4
About
Developer of novel implantable neuromodulation technology
Summary
Axonics is a Biotech company. It has raised $125.3M in total across 4 rounds, most recently a $20.1M Series D round in Apr 2018. Investors include Gilde Healthcare, Longitude Capital and Edmond de Rothschild Investment Partners.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2018
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.